Articles
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Millions of people globally experience some form of hair loss, which typically increases with age. Pattern baldness, also known as androgenic alopecia (AGA), is the leading type, affecting more than half of men over 50 and a significant portion…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Pattern hair loss (androgenic alopecia) is increasingly prevalent with age, affecting many adult men and women. Topical finasteride is one of the most proven treatments available. However, choosing the right provider can be challenging in today’s saturated market, which…
Nektar Therapeutics has announced topline results from its Phase 2b REZOLVE-AA trial evaluating rezpegaldesleukin (REZPEG) in patients with severe-to-very-severe alopecia areata (AA). The data establish clinical proof of concept and support advancement into Phase 3 development, positioning rezpegaldesleukin as a potential non-JAK option for this autoimmune hair-loss condition. What is Rezpegaldesleukin? Rezpegaldesleukin is a first-in-class…
Absci has announced that the first volunteers have now been dosed in its Phase 1/2a HEADLINE trial evaluating ABS-201, a novel anti-prolactin receptor (PRLR) antibody designed with the company’s generative AI platform. What is Absci? Absci is a biotech company focused on using generative AI and synthetic biology to design next-generation biologics. Their pitch is…
Cosmo Pharmaceuticals has announced impressive topline results from its two pivotal Phase 3 trials evaluating clascoterone 5% topical solution for male androgenic alopecia (AGA). These data mark what may be the first major therapeutic breakthrough for male-pattern hair loss in over 30 years. What is Clascoterone? Clascoterone is a topical androgen receptor inhibitor designed to…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Testosterone replacement therapy (TRT) can be a breakthrough for men with low testosterone levels. It has been shown to boost vitality, sexual function, muscle mass, and energy levels once lost to hormonal decline. However, this life-changing intervention is often…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. In recent years, topical dutasteride has captured increasing attention among people seeking alternatives to standard oral therapies, often due to intolerance or limited results. This surge is fueled by social media testimonials and before-and-after photos that highlight dramatic transformations.…
Veradermics, a clinical-stage dermatology company, announced on October 16 the completion of an oversubscribed $150 million Series C financing round. The funding will support the advancement of its lead investigational candidate, VDPHL01—an extended-release oral formulation of minoxidil being studied for androgenic alopecia in both men and women. The company describes it as the first oral…
A new contender in the dermatology field is GeneSkin, an mRNA-based platform developed at Harvard’s Wyss Institute, which aims to address some of the unmet needs in skin and hair health. The minds behind GeneSkin include geneticist George Church and his team, who have been studying which genes help skin and hair stay healthy. By…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Continuing our new approach, here is our complete guide to topical finasteride dosing. Top 3 Recommended Topical Finasteride Brands #1 Ulo (Editor’s Choice) #2 Hims #3 Keeps In this article, we’ll discuss the available clinical literature and how varying…